πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 37 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12414968

Compositions comprising bacterially derived minicells and methods of using the same

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12357687

Compositions and vaccines for treating and/or preventing viral infections, and methods of

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12337033

Encapsulated glycolipid antigens for treatment of neoplastic diseases

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11964021

Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11504402

Compositions comprising bacterially derived minicells and methods of using the same

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11485976

Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11357860

Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mamm

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11147883

Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mamm

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11052157

Enhanced loading of intact, bacterially derived vesicles with small molecule compounds

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10994014

Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10799461

Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10583200

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact mi

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10500277

Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and int

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10441546

Bacterially derived intact minicells that encompass plasmid free DNA and methods of using

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10426736

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact min

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10383827

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10328159

Enhanced loading of intact, bacterially derived vesicles with small molecule compounds

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10098847

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10076545

Pharmaceutically compatible method for purifying intact bacterial minicells

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9987377

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact mi

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9878043

Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mamm

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9867785

Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9844598

Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9730897

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact min

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted